Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Onconova Therapeutics, Inc.
Scientific Title
A Phase III, International, Randomized, Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent